Kwantas Corporation Berhad:企業の戦略・SWOT・財務分析

◆英語タイトル:Kwantas Corporation Berhad - Strategy, SWOT and Corporate Finance Report
◆商品コード:SWOT20MY4854
◆発行会社(調査会社):MarketLine
◆発行日:2020年2月
◆ページ数:31
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:マレーシア
◆産業分野:Consumer Packaged Goods
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Kwantas Corporation Berhad – Strategy, SWOT and Corporate Finance Report
Summary

Kwantas Corporation Berhad – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Kwantas Corporation Berhad (Kwantas) is an investment holding company that operates palm plantation and palm oil mills. The company’s product portfolio includes margarine, edible oils, soap noodle and cocoa butter substitute. It markets edible oils including palm and soya bean oil under Cap Sedap, Minyak Emas, Cap Payau and A one brand names. Kwantas manages and operates palm oil mills, palm plantations, palm and soya beans refinery plant, kernel crushing plant, and biomass power plant. It is also involved in trading of soya bean and palm oil, wholesale and supply of diesel and related products. The company also operates plants in Malaysia and China. Kwantas is headquartered in Kota Kinabalu, Sabah, Malaysia.

Scope

- Detailed information on Kwantas Corporation Berhad required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Kwantas Corporation Berhad in the form of a SWOT analysis
- An in-depth view of the business model of Kwantas Corporation Berhad including a breakdown and examination of key business segments
- Intelligence on Kwantas Corporation Berhad’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Kwantas Corporation Berhad, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Kwantas Corporation Berhad and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Kwantas Corporation Berhad as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Kwantas Corporation Berhad’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Table of Contents
Kwantas Corporation Berhad: Company Overview
Kwantas Corporation Berhad: Overview and Key Facts
Kwantas Corporation Berhad: Overview
Kwantas Corporation Berhad: Key Facts
Kwantas Corporation Berhad: Key Employees
Kwantas Corporation Berhad: Key Employee Biographies
Kwantas Corporation Berhad: Major Products and Services
Kwantas Corporation Berhad: Company History
Kwantas Corporation Berhad: Management Statement
Kwantas Corporation Berhad: Locations and Subsidiaries
Kwantas Corporation Berhad: Key Competitors
Kwantas Corporation Berhad: Company Analysis
Kwantas Corporation Berhad: Business Description
Kwantas Corporation Berhad: SWOT Analysis
Kwantas Corporation Berhad: SWOT Overview
Kwantas Corporation Berhad: Strengths
Kwantas Corporation Berhad: Weaknesses
Kwantas Corporation Berhad: Opportunities
Kwantas Corporation Berhad: Threats
Kwantas Corporation Berhad: Corporate Financial Deals Activity
Kwantas Corporation Berhad: Financial Deals Overview
Kwantas Corporation Berhad: Top Deals 2016 – 2020YTD*
Kwantas Corporation Berhad: Divestments
Appendix
Contact Us
Methodology
About MarketLine

List of Tables
Table 1: Kwantas Corporation Berhad: Key Facts
Table 2: Kwantas Corporation Berhad: Key Employees
Table 3: Kwantas Corporation Berhad: Company History
Table 4: Kwantas Corporation Berhad: Locations and Subsidiaries
Table 5: Kwantas Corporation Berhad: Key Competitors
Table 6: Kwantas Corporation Berhad: Deal Activity by Deal Type - Volume (2016 - YTD*2020)
Table 7: Kwantas Corporation Berhad: Top Deals 2016 - 2020YTD*
Table 8: Kwantas Corporation Berhad: Divestments Volume and Value Trend (2016 - YTD*2020)
Table 9: Kwantas Corporation Berhad: Divestments by Geography (2016 - YTD*2020)

★海外企業調査レポート[Kwantas Corporation Berhad:企業の戦略・SWOT・財務分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Harbin Electric Co Ltd (1133):企業の財務・戦略的SWOT分析
    Harbin Electric Co Ltd (1133) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Hanwei Energy Services Corp (HE):企業の財務・戦略的SWOT分析
    Summary Hanwei Energy Services Corp (Hanwei Energy) is a chemical company that develops, manufactures and distributes plastic fibre reinforced piping systems. The company’s products include anhydride and amine cured frp pipes, fittings, fixtures and flanges. It offers client solutions such as pre-te …
  • IRWIN Industrial Tool Co:企業の戦略的SWOT分析
    IRWIN Industrial Tool Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Navistar International Corp (NAV):企業の財務・戦略的SWOT分析
    Navistar International Corp (NAV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Provepharm life Solutions SA:製薬・医療:M&Aディール及び事業提携情報
    Summary Provepharm life Solutions SA (Provepharm) is a life sciences research and pharmaceutical company which focuses on innovative specialty care products for hospitals. The company’s product portfolio includes; methylthioninium chloride proveblue, provayblue methylene blue, proveblue methylene bl …
  • Puma Biotechnology Inc (PBYI):製薬・医療:M&Aディール及び事業提携情報
    Summary Puma Biotechnology Inc (Puma) is a biopharmaceutical company that develops novel therapeutics for the treatment of cancer. The company develops and commercializes three drug candidates, namely, PB272 (neratinib, oral), PB272 (neratinib, intravenous) and PB357. Its pipeline portfolio also enc …
  • AutoNation Inc (AN):企業の財務・戦略的SWOT分析
    AutoNation Inc (AN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • ratiopharm GmbH:企業の戦略的SWOT分析
    ratiopharm GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Dr. Paul Lohmann GmbH & Co KGaA:企業の戦略・SWOT・財務分析
    Dr. Paul Lohmann GmbH & Co KGaA - Strategy, SWOT and Corporate Finance Report Summary Dr. Paul Lohmann GmbH & Co KGaA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • McLane Company Inc:企業の戦略・SWOT・財務情報
    McLane Company Inc - Strategy, SWOT and Corporate Finance Report Summary McLane Company Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Ubisoft Entertainment S.A.:企業の戦略・SWOT・財務情報
    Ubisoft Entertainment S.A. - Strategy, SWOT and Corporate Finance Report Summary Ubisoft Entertainment S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Magellan Health, Inc.:企業の戦略・SWOT・財務情報
    Magellan Health, Inc. - Strategy, SWOT and Corporate Finance Report Summary Magellan Health, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Ultrapar Participacoes S.A.:企業の戦略・SWOT・財務情報
    Ultrapar Participacoes S.A. - Strategy, SWOT and Corporate Finance Report Summary Ultrapar Participacoes S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • CTBC Financial Holding Co Ltd (2891):企業の財務・戦略的SWOT分析
    CTBC Financial Holding Co Ltd (2891) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Bellerophon Therapeutics Inc (BLPH):医療機器:M&Aディール及び事業提携情報
    Summary Bellerophon Therapeutics Inc (Bellerophon Therapeutics), formerly Bellerophon Therapeutics LLC is a clinical-stage biotherapeutics company that focuses on the development of therapies for the treatment of cardiopulmonary diseases. The company’s lead investigational cardiopulmonary product ca …
  • China Vanke Co., Ltd.:企業のM&A・事業提携・投資動向
    China Vanke Co., Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's China Vanke Co., Ltd. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M …
  • Gedeon Richter Plc:企業のM&A・事業提携・投資動向
    Gedeon Richter Plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Gedeon Richter Plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), d …
  • Empresas Copec S.A.:企業の戦略・SWOT・財務情報
    Empresas Copec S.A. - Strategy, SWOT and Corporate Finance Report Summary Empresas Copec S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • amcure GmbH-製薬・医療分野:企業M&A・提携分析
    Summary amcure GmbH (Amcure) is biopharmaceutical company which discovers and develops therapeutics for the treatment of cancer. It develops peptide-based compounds for the treatment of metastatic forms of cancer. The company’s lead candidate AMC303, is in Phase I clinical trial and used for the tre …
  • Pharco Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Pharco Pharmaceuticals Inc (Pharco Pharmaceuticals), a subsidiary of Pharco Corp, is a manufacturer of branded and generic pharmaceutical products. The company offers products such as alambupine, alfatral, amlodipine, amrase, amrizole, bisadyl, bromhexine, carbolase, ciprofloxacin, dexametha …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆